Abstract
Escherichia coli is one of the most important microbial cell factories, but infection by bacteriophages in the environment may have a huge impact on its application in industrial production. Here, we developed a mobile CRISPR-Cas9 based anti-phage system for bacteriophages defense in E. coli. Two conjugative plasmids pGM1 (phosphoglucomutase 1) and pGM2 carrying one and two guide RNAs, respectively, were designed to defend against a filamentous phage. The results showed that the pGM1 and pGM2 could decrease the phage infection rate to 1.6% and 0.2% respectively in infected cells. For preventing phage infection in E. coli, the pGM2 decreased the phage infection rate to 0.1 %, while pGM1 failed to block phage infection. Sequence verification revealed that point mutations in protospacer or protospacer adjacent motif sequences of the phage genome caused loss of the defense function. These results support the potential application of MCBAS in E. coli cell factories to defend against phage infections.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Li J, Neubauer P. Escherichia coli as a cell factory for heterologous production of nonribosomal peptides and polyketides. New Biotechnology, 2014, 31(6): 579–585
Baeshen N A, Baeshen M N, Sheikh A, Bora R S, Ahmed M M M, Ramadan H A I, Saini K S, Redwan E M. Cell factories for insulin production. Microbial Cell Factories, 2014, 13(1): 141
Wang Z, Sun J, Yang Q, Yang J. Metabolic engineering Escherichia coli for the production of lycopene. Molecules (Basel, Switzerland), 2020, 25(14): 3136
Lemuth K, Steuer K, Albermann C. Engineering of a plasmid-free Escherichia coli strain for improved in vivo biosynthesis of astaxanthin. Microbial Cell Factories, 2011, 10(1): 29
Li M, Nian R, Xian M, Zhang H. Metabolic engineering for the production of isoprene and isopentenol by Escherichia coli. Applied Microbiology and Biotechnology, 2018, 102(18): 7725–7738
Zhao C, Zhang Y, Li Y. Production of fuels and chemicals from renewable resources using engineered Escherichia coli. Biotechnology Advances, 2019, 37(7): 107402
Wu H, Fan Z, Jiang X, Chen J, Chen G. Enhanced production of polyhydroxybutyrate by multiple dividing E. coli. Microbial Cell Factories, 2016, 15(1): 128
Chen G, Jiang X. Engineering bacteria for enhanced polyhydroxyalkanoates (PHA) biosynthesis. Synthetic and Systems Biotechnology, 2017, 2(3): 192–197
Liu X, Hua K, Liu D, Wu Z, Wang Y, Zhang H, Deng Z, Pfeifer B A, Jiang M. Heterologous biosynthesis of type II polyketide products using E. coli. ACS Chemical Biology, 2020, 15(5): 1177–1183
Tang Y, Wang M, Qin H, An X, Guo Z, Zhu G, Zhang L, Chen Y. Deciphering the biosynthesis of TDP-α-L-oleandrose in avermectin. Journal of Natural Products, 2020, 83(10): 3199–3206
Jones D T, Shirley M, Wu X Y, Keis S. Bacteriophage infections in the industrial acetone butanol (AB) fermentation process. Journal of Molecular Microbiology and Biotechnology, 2000, 2(1): 21–26
Chaturongakul S, Ounjai P. Phage-host interplay: examples from tailed phages and Gram-negative bacterial pathogens. Frontiers in Microbiology, 2014, 5: 442
Kronheim S, Daniel I M, Duan Z, Hwang S, Wong A I, Mantel I, Nodwell J R, Maxwell K L. A chemical defence against phage infection. Nature, 2018, 564(7735): 283–286
Abedon S T. Bacteriophage secondary infection. Virologica Sinica, 2015, 30(1): 3–10
Hampton H G, Watson B N J, Fineran P C. The arms race between bacteria and their phage foes. Nature, 2020, 577(7790): 327–336
Scholl D, Adhya S, Merril C. Escherichia coli K1’s capsule is a barrier to bacteriophage T7. Applied and Environmental Microbiology, 2005, 71(8): 4872–4874
Vasu K, Nagaraja V. Diverse functions of restriction-modification systems in addition to cellular defense. Microbiology and Molecular Biology Reviews, 2013, 77(1): 53–72
Pleska M, Guet C C. Effects of mutations in phage restriction sites during escape from restriction-modification. Biology Letters, 2017, 13(12): 20170646
Zhou Y, Xu X, Wei Y, Cheng Y, Guo Y, Khudyakov I, Liu F, He P, Song Z, Li Z, et al. A widespread pathway for substitution of adenine by diaminopurine in phage genomes. Science, 2021, 372 (6541): 512–516
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero D A, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007, 315(5819): 1709–1712
Smith G P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228 (4705): 1315–1317
Esvelt K M, Carlson J C, Liu D R. A system for the continuous directed evolution of biomolecules. Nature, 2011, 472(7344): 499–550
Carlson J C, Badran A H, Guggiana N D A, Liu D R. Negative selection and stringency modulation in phage-assisted continuous evolution. Nature Chemical Biology, 2014, 10(3): 216–222
Bryson D I, Fan C, Guo L, Miller C, Soll D, Liu D R. Continuous directed evolution of aminoacyl-tRNA synthetases. Nature Chemical Biology, 2018, 14(2): 186
de Leeuw M, Baron M, David O B, Kushmaro A. Molecular insights into bacteriophage evolution toward its host. Viruses, 2020, 12(10): 1132
Chayot R, Montagne B, Mazel D, Ricchetti M. An end-joining repair mechanism in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(5): 2141–2146
Liu L, Zhao D, Ye L, Zhan T, Xiong B, Hu M, Bi C, Zhang X. A programmable CRISPR/Cas9-based phage defense system for Escherichia coli BL21(DE3). Microbial Cell Factories, 2020, 19 (1): 136
Dong H, Xiang H, Mu D, Wang D, Wang T. Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. International Journal of Antimicrobial Agents, 2019, 53(1): 1–8
Xie Z X, Li B Z, Mitchell L A, Wu Y, Qi X, Jin Z, Jia B, Wang X, Zeng B X, Liu H M, et al. “Perfect” designer chromosome V and behavior of a ring derivative. Science, 2017, 355(6329): 1046
Wu Y, Li B Z, Zhao M, Mitchell L A, Xie Z X, Lin Q H, Wang X, Xiao W H, Wang Y, Zhou X, et al. Bug mapping and fitness testing of chemically synthesized chromosome X. Science, 2017, 355 (6329): 1048
Chen W G, Han M Z, Zhou J T, Ge Q, Wang P P, Zhang X C, Zhu S Y, Song L F, Yuan Y J. An artificial chromosome for data storage. National Science Review, 2021, 8(5): 62–70
Wang L, Jiang S, Chao C, He W, Wu X, Wang F, Tong T, Zou X, Li Z, Luo J, et al. Synthetic genomics: from DNA synthesis to genome design. Angewandte Chemie International Edition, 2018, 57(7): 1748–1756
Cello J, Paul A V, Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science, 2002, 297(5583): 1016–1018
Smith H O, Iii C A H, Pfannkoch C, Venter J C. Generating a synthetic genome by whole genome assembly: X174 bacteriophage from synthetic oligonucleotides. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100 (26): 15440–15445
Chan L Y, Kosuri S, Endy D. Refactoring bacteriophage T7. Molecular Systems Biology, 2005, 1: 2005.0018
Thao T, Labroussaa F, Ebert N, Kovski P V, Thiel V. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature, 2020, 582(7813): 561–565
Zhang J, Zhang D, Zhu J, Liu H, Liang S, Luo Y. Efficient multiplex genome editing in Streptomyces via engineered CRISPR-Cas12a systems. Frontiers in Bioengineering and Biotechnology, 2020, 8: 726
Wang L, Wang H, Liu H, Zhao Q, Liu B, Wang L, Zhang J, Zhu J, Bao R, Luo Y. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing. Biotechnology and Bioengineering, 2019, 116(6): 1463–1474
Liu H, Wang L, Luo Y. Blossom of CRISPR technologies and applications in disease treatment. Synthetic and Systems Biotechnology, 2018, 3(4): 217–228
Acknowledgements
The authors are grateful for the financial support from the National Key Research and Development Program of China (Grant No. 2019YFA0903800), the National Natural Science Foundation of China (Grant Nos. 31800719, 21621004), and the International (regional) cooperation and exchange projects (Grant No. 31861143017).
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Cao, Z., Ma, Y., Jia, B. et al. Mobile CRISPR-Cas9 based anti-phage system in E. coli. Front. Chem. Sci. Eng. 16, 1281–1289 (2022). https://doi.org/10.1007/s11705-022-2141-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11705-022-2141-7